Women's Health News

RSS

Study highlights need for public education on osteoporosis risk factors and treatment

Underscoring what researchers call a serious international public health concern, results from the Global Longitudinal Study of Osteoporosis in Women (GLOW) showed that among women at an elevated level of risk for osteoporosis-associated fractures, there is a failure to perceive the implications of having important risk factors.

3 Apr 2010

Recent releases in Global Health

"Achieving the [Millennium Development Goal] MDG 4 target of reducing newborn and child mortality will require concerted efforts to scale up evidence-based interventions, especially community-based preventive and therapeutic strategies in primary care," according to a Lancet comment that reflects on the challenges associated with developing "the appropriate mix of strategies" to improve maternal health.

3 Apr 2010

NAFC supports PMAA of Uromedica's ACT device for SUI, speaks to FDA

On March 24, Nancy Muller, executive director of The National Association For Continence (NAFC), spoke to the Food and Drug Administration (FDA), in support of a Premarket Approval Application (PMAA) of Uromedica, Inc.'s Adjustable Continence Therapy (ACT®) device to approve its usage in the U.S. The ACT is designed to treat female stress urinary incontinence (SUI).

2 Apr 2010

U.S. Court finds Teva Pharmaceutical Industries' Seasonique patent valid and enforceable

Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Nevada has granted Teva's Motion for Summary Judgment with respect to the validity of U.S. Patent No. 7,320,969. In March 2008, Duramed, now Teva Women's Health, brought suit in the District of Nevada against Watson alleging infringement of Teva's patent as a result of Watson's filing of an Abbreviated New Drug Application (ANDA) for Seasonique®.

2 Apr 2010

UVA's DMT scanner helps detect breast cancer undetectable with mammography, MRI or needle biopsy

Perhaps no one can appreciate the importance of early cancer detection as much as Izora Armstrong. That's because UVA Cancer Center researchers, using a first-of-its-kind hybrid breast imaging device, found what mammography, ultrasound, MRI and even a needle biopsy couldn't.

2 Apr 2010

Extending breast cancer screening to younger women will benefit in terms of economic efficiency and equity

Screening younger women for breast cancer is fairer and makes sound economic sense, according to new research by the University of East Anglia (UEA).

2 Apr 2010

Canadians can join Canadian Cancer Society in the fight against cancer

With the support of generous corporate partners, the Canadian Cancer Society is fighting back against cancer. This April, the Society will raise funds and awareness in partnership with companies across Canada. Supporting the companies that support the Canadian Cancer Society is another way Canadians can join the fight against cancer.

1 Apr 2010

Perception, rather than actual sleep quality may predict postpartum mood disturbances in new mothers

A study of healthy new mothers in the April 1 issue of the journal Sleep found that the perception of poor sleep and the conscious awareness of its impact on daytime functioning might be stronger predictors of immediate postpartum mood disturbances than actual sleep quality and quantity.

1 Apr 2010

Physicians can increase accuracy of clinical breast examinations using attention-focusing forms

Using a simple form to help focus their attention can help physicians increase the quality and accuracy of clinical breast examinations, increasing the likelihood of detecting cancers missed by mammograms. That's the finding of a new study coming out in the April 1st issue of The American Journal of Medicine.

1 Apr 2010

Newsweek examines challenges associated wtih U.S. food aid program

Newsweek examines how the U.S. farm bill influences food aid by tracking the efforts of U.S. entrepreneur Navyn Salem as she worked to launch a nonprofit capable of providing ready-to-use therapeutic (RUTF) food aid known as Plumpy'nut - "a squeezable package of fortified peanut-butter-based paste … used to feed severely malnourished children and pregnant or lactating women" - to NGOs that contract with USAID.

1 Apr 2010

Lifetime Television to feature XenaCare Holdings' OTC pain reliever Cobroxin

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that its over-the-counter (OTC) pain reliever, Cobroxin, will be featured on a segment of The Balancing Act, a morning show that airs on the top-rated women's cable television network, Lifetime Television.

1 Apr 2010

Also in Global Health News: HIV/AIDS in Central Asia; Nigeria MDGs; Aid transparency; Maternal health in Peru

Aljazerra.net reports on the spread of HIV/AIDS throughout Central Asia along drug routes in the region. The piece examines the lack of information available to the people of Central Asia about HIV prevention strategies and a recent effort among a group of Muslim imams in Tajikistan to educate people about the disease (Andersen, 3/31).

1 Apr 2010

Family planning, access to safe, legal abortion key to maternal, child health, U.S. Sec. of State says

Following a two-day meeting of foreign ministers from G8 countries in Quebec on Tuesday, Secretary of State Hillary Rodham Clinton "appeared at odds … with [Canadian] Prime Minister Stephen Harper's G8 initiative on maternal and child health, saying family planning, contraception and access to legal, safe abortions were vital elements of maternal health care," Canwest News Service/Ottawa Citizen report (O'Neill, 3/31).

1 Apr 2010

Link between occupational exposures and postmenopausal breast cancer

Occupational exposure to certain chemicals and pollutants before a woman reaches her mid-30s could treble her risk of developing cancer after the menopause, suggests research published in Occupational and Environmental Medicine .

1 Apr 2010

Structured and supervised exercise can prevent postnatal depression, says study

Postnatal depression (PND) or baby blues are a recognized entity with millions of mothers suffering from it in varying degrees. It affects 13% of the new mothers usually within the first 3 months after the birth of the baby.

1 Apr 2010

Breastfeeding benefits expanded to cover mothers: Risk of diabetes reduced

Research has found a new benefit that mothers can obtain by breast feeding – decreased risk of type 2 diabetes. Benefits of breastfeeding for the baby have been cited for a long time now. In spite of this knowledge according to The Australian Breastfeeding Association there is a definite gap in awareness regarding health benefits that this simple yet effective practice can offer.

1 Apr 2010

VIVUS terminates Luramist development, commercialization agreement with FemPharm

VIVUS, Inc. today announced that it has terminated the Development and Commercialization Agreement with FemPharm Pty Ltd. (a wholly owned subsidiary of Acrux Limited) for Luramist™, a metered dose transdermal application of testosterone for women.

1 Apr 2010

Court rules against gene patents

The New York Times: A judicial ruling that "threw out parts of two gene patents and called into question thousands more" has biotechnology executives hastening "to reassure their investors that the ruling would not necessarily undermine their businesses, at least in the short run. But the executives themselves were struggling on Tuesday to figure out what the long-term impact would be."

1 Apr 2010

Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer

Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.

31 Mar 2010

Fourth biennial BHGI Global Summit on International Breast Health

The Breast Health Global Initiative and the Latin American & Caribbean Society of Medical Oncology will convene the fourth biennial BHGI Global Summit on International Breast Health June 9-11, 2010 in Chicago, bringing together collaborating national and international organizations to address the optimization of breast health care delivery in limited-resource countries.

31 Mar 2010

Women's Health News

Study highlights need for public education on osteoporosis risk factors and treatment

Recent releases in Global Health

NAFC supports PMAA of Uromedica's ACT device for SUI, speaks to FDA

U.S. Court finds Teva Pharmaceutical Industries' Seasonique patent valid and enforceable

UVA's DMT scanner helps detect breast cancer undetectable with mammography, MRI or needle biopsy

Extending breast cancer screening to younger women will benefit in terms of economic efficiency and equity

Canadians can join Canadian Cancer Society in the fight against cancer

Perception, rather than actual sleep quality may predict postpartum mood disturbances in new mothers

Physicians can increase accuracy of clinical breast examinations using attention-focusing forms

Newsweek examines challenges associated wtih U.S. food aid program

Lifetime Television to feature XenaCare Holdings' OTC pain reliever Cobroxin

Also in Global Health News: HIV/AIDS in Central Asia; Nigeria MDGs; Aid transparency; Maternal health in Peru

Family planning, access to safe, legal abortion key to maternal, child health, U.S. Sec. of State says

Link between occupational exposures and postmenopausal breast cancer

Structured and supervised exercise can prevent postnatal depression, says study

Breastfeeding benefits expanded to cover mothers: Risk of diabetes reduced

VIVUS terminates Luramist development, commercialization agreement with FemPharm

Court rules against gene patents

Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer

Fourth biennial BHGI Global Summit on International Breast Health

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News